A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol

Abstract Background Concurrent chemoradiotherapy is a standard modality for locally advanced esophageal squamous cell carcinoma (ESCC) patients. Cisplatin combined with 5-fluorouracil continuous infusion (PF) remains the standard concurrent chemotherapy regimen. However, radiotherapy concurrent with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yun Chen, Zhengfei Zhu, Weixin Zhao, Ling Li, Jinjun Ye, Chaoyang Wu, Huarong Tang, Qin Lin, Jiancheng Li, Yi Xia, Yunhai Li, Jialiang Zhou, Kuaile Zhao
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2018-02-01
Colecção:Radiation Oncology
Assuntos:
Esophageal squamous cell carcinoma
Concurrent chemoradiotherapy
Paclitaxel
Cisplatin
5-fluorouracil
Acesso em linha:http://link.springer.com/article/10.1186/s13014-018-0979-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados